Sanofi Increase Decrease In Contingent Consideration Asset Liability
Sanofi (SNYNF) reported Increase Decrease In Contingent Consideration Asset Liability of EUR 104.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability · last filed 2026-02-17
| Period end | Increase Decrease In Contingent Consideration Asset Liability 6 month | Increase Decrease In Contingent Consideration Asset Liability 12 month |
|---|---|---|
| 2025-12-31 | 104.00M EUR 20-F · filed 2026-02-17 | |
| 2025-06-30 | 61.00M EUR 6-K · filed 2025-10-27 | |
| 2024-12-31 | 96.00M EUR 20-F · filed 2026-02-17 | |
| 2024-06-30 | 66.00M EUR 6-K · filed 2025-10-27 | |
| 2023-12-31 | 93.00M EUR 20-F · filed 2026-02-17 | |
| 2023-06-30 | 26.00M EUR 6-K · filed 2024-07-25 | |
| 2022-12-31 | -27.00M EUR 20-F · filed 2025-02-13 | |
| 2022-06-30 | 17.00M EUR 6-K · filed 2023-07-28 | |
| 2021-12-31 | 4.00M EUR 20-F · filed 2024-02-23 | |
| 2021-06-30 | 4.00M EUR 6-K · filed 2022-07-28 | |
| 2020-12-31 | -124.00M EUR 20-F · filed 2023-02-24 | |
| 2020-06-30 | -54.00M EUR 6-K · filed 2021-07-29 | |
| 2019-12-31 | -238.00M EUR 20-F · filed 2022-02-23 |